A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 16 Issue 4 November 2022) has been published and includes articles on:
Dupilumab (Dupixent▼): risk of ocular adverse reactions and need for prompt management
Consultation with healthcare professionals: please complete our consultation to help influence how we communicate with you
COVID-19 vaccines and medicines: updates for November 2022
Letters and medicine recalls sent to healthcare professionals in October 2022
To see the latest MHRA Drug Safety Updates in full, visit the GOV.uk website.
The post MHRA Drug Safety Update November 2022 appeared first on PSNC Website.